Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study.

BACKGROUND Experimental studies in animals and cross-sectional studies in humans have suggested that low serum magnesium levels might lead to type 2 diabetes; however, this association has not been examined prospectively. METHODS We assessed the risk for type 2 diabetes associated with low serum magnesium level and low dietary magnesium intake in a cohort of nondiabetic middle-aged adults (N = 12,128) from the Atherosclerosis Risk in Communities Study during 6 years of follow-up. Fasting serum magnesium level, categorized into 6 levels, and dietary magnesium intake, categorized into quartiles, were measured at the baseline examination. Incident type 2 diabetes was defined by self-report of physician diagnosis, use of diabetic medication, fasting glucose level of at least 7.0 mmol/L (126 mg/dL), or nonfasting glucose level of at least 11.1 mmol/L (200 mg/dL). RESULTS Among white participants, a graded inverse relationship between serum magnesium levels and incident type 2 diabetes was observed. From the highest to the lowest serum magnesium levels, there was an approximate 2-fold increase in incidence rate (11.1, 12.2, 13.6, 12.8, 15.8, and 22.8 per 1000 person-years; P = .001). This graded association remained significant after simultaneous adjustment for potential confounders, including diuretic use. Compared with individuals with serum magnesium levels of 0.95 mmol/L (1.90 mEq/L) or greater, the adjusted relative odds of incident type 2 diabetes rose progressively across the following lower magnesium categories: 1.13 (95% CI, 0.79-1.61), 1.20 (95% CI, 0.86-1.68), 1.11 (95% CI, 0.80-1.56), 1.24 (95% CI, 0.86-1.78), and 1.76 (95% CI, 1.18-2.61) (for trend, P = .01). In contrast, little or no association was observed in black participants. No association was detected between dietary magnesium intake and the risk for incident type 2 diabetes in black or white participants. CONCLUSIONS Among white participants, low serum magnesium level is a strong, independent predictor of incident type 2 diabetes. That low dietary magnesium intake does not confer risk for type 2 diabetes implies that compartmentalization and renal handling of magnesium may be important in the relationship between low serum magnesium levels and the risk for type 2 diabetes.

[1]  C. Christiansen,et al.  Renal hypomagnesaemia in human diabetes mellitus: its relation to glucose homeostasis , 1982, European journal of clinical investigation.

[2]  L. Breum,et al.  The effect of intravenous magnesium therapy on serum and urine levels of potassium, calcium, and sodium in patients with ischemic heart disease, with and without acute myocardial infarction. , 1988, Archives of internal medicine.

[3]  E. Ravussin,et al.  Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. , 1995, The Journal of clinical endocrinology and metabolism.

[4]  R. Elin,et al.  Assessment of magnesium status. , 1987, Clinical chemistry.

[5]  Y. Rayssiguier,et al.  The effect of magnesium deficiency on glucose stimulated insulin secretion in rats. , 1983, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[6]  J. Nadler,et al.  Insulin increases intracellular magnesium transport in human platelets. , 1993, The Journal of clinical endocrinology and metabolism.

[7]  F. Lowenstein,et al.  Serum magnesium levels in the United States, 1971-1974. , 1986, Journal of the American College of Nutrition.

[8]  A. Somlyo,et al.  Effect of magnesium on posterior pituitary hormone action on vascular smooth muscle. , 1966, The American journal of physiology.

[9]  W. Wacker THE BIOCHEMISTRY OF MAGNESIUM * , 1969, Annals of the New York Academy of Sciences.

[10]  G. Paolisso,et al.  Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM Subjects , 1989, Diabetes Care.

[11]  P. H. Petersen,et al.  Biological variation of serum and urinary magnesium in apparently healthy males. , 1995, Scandinavian journal of clinical and laboratory investigation.

[12]  P. Metcalf,et al.  Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. , 1995, Journal of clinical epidemiology.

[13]  R. Campbell,et al.  Magnesium and Diabetes: A Review , 1993, The Annals of pharmacotherapy.

[14]  G. Dohm,et al.  Liver Glucokinase: Decreased Activity in Patients with Type II Diabetes , 1995, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[15]  H. Beck-Nielsen,et al.  Insulin Increases Renal Magnesium Excretion: A Possible Cause of Magnesium Depletion in Hyperinsulinaemic States , 1995, Diabetic medicine : a journal of the British Diabetic Association.

[16]  N. Ward,et al.  Fasting plasma magnesium concentrations and glucose disposal in diabetes. , 1984, British medical journal.

[17]  J E Frijters,et al.  A short questionnaire for the measurement of habitual physical activity in epidemiological studies. , 1982, The American journal of clinical nutrition.

[18]  T R Pilkington,et al.  Hypomagnesaemia in diabetes. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[19]  W. Willett,et al.  The use of a self-administered questionnaire to assess diet four years in the past. , 1988, American journal of epidemiology.

[20]  F M Matschinsky,et al.  Glucokinase as Glucose Sensor and Metabolic Signal Generator in Pancreatic β-Cells and Hepatocytes , 1990, Diabetes.

[21]  R. Elin,et al.  Magnesium metabolism in health and disease. , 1988, Disease-a-month : DM.

[22]  R. Rizza,et al.  Effects of insulin on plasma magnesium in noninsulin-dependent diabetes mellitus: evidence for insulin resistance. , 1995, The Journal of clinical endocrinology and metabolism.

[23]  R. Hanson,et al.  Comparison of screening tests for non-insulin-dependent diabetes mellitus. , 1993, Archives of internal medicine.

[24]  G. Paolisso,et al.  Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. , 1994, The Journal of clinical endocrinology and metabolism.

[25]  H. V. Connerty,et al.  Determination of serum calcium by means of orthocresolphthalein complexone. , 1966, American journal of clinical pathology.

[26]  J. Laragh,et al.  Cellular Ions in Hypertension, Diabetes, and Obesity A Nuclear Magnetic Resonance Spectroscopic Study , 1991, Hypertension.

[27]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[28]  J. Gu,et al.  Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. , 1995, The American journal of physiology.

[29]  R. Rude,et al.  Determination of intracellular free magnesium by nuclear magnetic resonance in human magnesium deficiency. , 1989, Journal of the American College of Nutrition.

[30]  J. Manson,et al.  Diet and risk of clinical diabetes in women. , 1992, The American journal of clinical nutrition.

[31]  S. Haffner Risk factors for non-insulin-dependent diabetes mellitus , 1995, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[32]  W. Willett,et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire. , 1985, American journal of epidemiology.

[33]  G. Paolisso,et al.  Dietary magnesium supplements improve B-cell response to glucose and arginine in elderly non-insulin dependent diabetic subjects. , 1989, Acta endocrinologica.

[34]  Y. Rayssiguier,et al.  Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats. , 1989, The American journal of physiology.

[35]  G. Paolisso,et al.  Daily magnesium supplements improve glucose handling in elderly subjects. , 1992, The American journal of clinical nutrition.